Indian pharma major Piramal Pharma Solutions (PPS) has won the ‘Regulatory Procedures and Compliance’ award at the prestigious CPhI Pharma Awards (2017) held on October 24 at the Intercontinental Hotel – Frankfurt, Germany.
The company competed with several of its global peers in this category. “The award serves as a testament to our efforts that advances Piramal Pharma Solutions from ‘Quality for Compliance’ to ‘Quality as a Culture’. Our ‘One Piramal’ strategy is built around the values of Customer Centricity, Quality, and Innovation,” said Vivek Sharma, Chief Executive Officer of Piramal Pharma Solutions, after receiving the award.
“It is great to be recognised by our fellow peers and customers on one of our core values. We recognise that as an industry, we serve a higher purpose: Delivering solutions for our customers that improve the standard of life and reduce the burden of disease in patients,” he added.
PPS is a leading global Contract Development and Manufacturing Organisation (CDMO), with 12 locations in North America, Europe, and Asia, driving solutions for our customers, from discovery through commercialisation.
The CPhI Pharma Awards are among the most coveted recognitions in the pharmaceutical industry and celebrates thinkers and creators that break new ground, recognising companies that drive the industry forward. With over 200 entries submitted in 19 different award categories, the CPhI Pharma Awards serve as a great barometer for industry excellence.
